156 related articles for article (PubMed ID: 19331662)
1. Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancer.
Chen H; Yue JX; Yang SH; Ding H; Zhao RW; Zhang S
J Exp Clin Cancer Res; 2009 Mar; 28(1):43. PubMed ID: 19331662
[TBL] [Abstract][Full Text] [Related]
2. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo.
Yuan W; Wu S; Guo J; Chen Z; Ge J; Yang P; Hu B; Chen Z
Cancer Biol Ther; 2010 May; 9(9):710-6. PubMed ID: 20200485
[TBL] [Abstract][Full Text] [Related]
3. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells.
Xu X; Zur Hausen A; Coy JF; Löchelt M
Int J Cancer; 2009 Mar; 124(6):1330-7. PubMed ID: 19065656
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: a potential therapeutic target in nasopharyngeal carcinoma.
Zhang S; Yue JX; Yang JH; Cai PC; Kong WJ
Cancer Biol Ther; 2008 Apr; 7(4):517-22. PubMed ID: 18296915
[TBL] [Abstract][Full Text] [Related]
5. Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells.
Zhang S; Yang JH; Guo CK; Cai PC
Cancer Lett; 2007 Aug; 253(1):108-14. PubMed ID: 17321041
[TBL] [Abstract][Full Text] [Related]
6. TKTL1 expression and its downregulation is implicated in cell proliferation inhibition and cell cycle arrest in esophageal squamous cell carcinoma.
Shi Z; Tang Y; Li K; Fan Q
Tumour Biol; 2015 Nov; 36(11):8519-29. PubMed ID: 26032094
[TBL] [Abstract][Full Text] [Related]
7. The human transketolase-like proteins TKTL1 and TKTL2 are bona fide transketolases.
Deshpande GP; Patterton HG; Faadiel Essop M
BMC Struct Biol; 2019 Jan; 19(1):2. PubMed ID: 30646877
[TBL] [Abstract][Full Text] [Related]
8. Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation.
Heller S; Maurer GD; Wanka C; Hofmann U; Luger AL; Bruns I; Steinbach JP; Rieger J
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044385
[TBL] [Abstract][Full Text] [Related]
9. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells.
Hu LH; Yang JH; Zhang DT; Zhang S; Wang L; Cai PC; Zheng JF; Huang JS
Anticancer Drugs; 2007 Apr; 18(4):427-33. PubMed ID: 17351395
[TBL] [Abstract][Full Text] [Related]
10. Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.
Jayachandran A; Lo PH; Chueh AC; Prithviraj P; Molania R; Davalos-Salas M; Anaka M; Walkiewicz M; Cebon J; Behren A
BMC Cancer; 2016 Feb; 16():134. PubMed ID: 26907172
[TBL] [Abstract][Full Text] [Related]
11. Expression of transketolase-like 1 (TKTL1) and p-Akt correlates with the progression of cervical neoplasia.
Kohrenhagen N; Voelker HU; Schmidt M; Kapp M; Krockenberger M; Frambach T; Dietl J; Kammerer U
J Obstet Gynaecol Res; 2008 Jun; 34(3):293-300. PubMed ID: 18686341
[TBL] [Abstract][Full Text] [Related]
12. The role of transketolase in human cancer progression and therapy.
Hao S; Meng Q; Sun H; Li Y; Li Y; Gu L; Liu B; Zhang Y; Zhou H; Xu Z; Wang Y
Biomed Pharmacother; 2022 Oct; 154():113607. PubMed ID: 36030587
[TBL] [Abstract][Full Text] [Related]
13. Transketolase-like protein 1 confers resistance to serum withdrawal in vitro.
Hartmannsberger D; Mack B; Eggert C; Denzel S; Stepp H; Betz CS; Gires O
Cancer Lett; 2011 Jan; 300(1):20-9. PubMed ID: 20884117
[TBL] [Abstract][Full Text] [Related]
14. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.
Langbein S; Zerilli M; Zur Hausen A; Staiger W; Rensch-Boschert K; Lukan N; Popa J; Ternullo MP; Steidler A; Weiss C; Grobholz R; Willeke F; Alken P; Stassi G; Schubert P; Coy JF
Br J Cancer; 2006 Feb; 94(4):578-85. PubMed ID: 16465194
[TBL] [Abstract][Full Text] [Related]
15. A δ38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity.
Schneider S; Lüdtke S; Schröder-Tittmann K; Wechsler C; Meyer D; Tittmann K
PLoS One; 2012; 7(10):e48321. PubMed ID: 23118983
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer.
Bentz S; Cee A; Endlicher E; Wojtal KA; Naami A; Pesch T; Lang S; Schubert P; Fried M; Weber A; Coy JF; Goelder S; Knüchel R; Hausmann M; Rogler G
Digestion; 2013; 88(3):182-92. PubMed ID: 24193262
[TBL] [Abstract][Full Text] [Related]
17. [Effects of transketolase-like gene TKTL1 on occurrence and metastasis of human nasopharyngeal carcinoma].
Zhang S; Yang JH; Cai PC
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3131-4. PubMed ID: 19159596
[TBL] [Abstract][Full Text] [Related]
18. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.
Qin Z; Xiang C; Zhong F; Liu Y; Dong Q; Li K; Shi W; Ding C; Qin L; He F
J Exp Clin Cancer Res; 2019 Apr; 38(1):154. PubMed ID: 30971297
[TBL] [Abstract][Full Text] [Related]
19. Evidence for transketolase-like TKTL1 flux in CHO cells based on parallel labeling experiments and (13)C-metabolic flux analysis.
Ahn WS; Crown SB; Antoniewicz MR
Metab Eng; 2016 Sep; 37():72-78. PubMed ID: 27174718
[TBL] [Abstract][Full Text] [Related]
20. A key role for transketolase-like 1 in tumor metabolic reprogramming.
Diaz-Moralli S; Aguilar E; Marin S; Coy JF; Dewerchin M; Antoniewicz MR; Meca-Cortés O; Notebaert L; Ghesquière B; Eelen G; Thomson TM; Carmeliet P; Cascante M
Oncotarget; 2016 Aug; 7(32):51875-51897. PubMed ID: 27391434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
